N/A
N=54
Evaluation of White Sweet Potato Tube Feeding Formula on Type 2 Diabetic Residents in Long-term Care Institutions
Type 2 Diabetes
Bottom Line
View on ClinicalTrials.gov: NCT02711839 ↗Enrolled (actual)
54
Serious AEs
0.0%
Results posted
Jul 2019
Primary outcome: Primary: HbA1c After Intervention — 6.8; 6.4 percentage
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Commercial diabetic formula (Dietary_supplement); White sweet potato formula (Dietary_supplement)
- Age
- Adult, Older Adult · 30+ yrs
- Sex
- All
- Sponsor
- Taipei Medical University
- Primary completion
- Nov 2016
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY HbA1c After Intervention |
6.8; 6.4 | — |
| SECONDARY Albumin After Intervention |
3.4; 3.6 | — |
| SECONDARY Glucose After Intervention |
126.7; 131.0 | — |
| SECONDARY Total Cholesterol After Intervention |
180.0; 150.1 | — |
| SECONDARY Triglyceride After Intervention |
214.3; 145.4 | — |
Summary
In order to response the increasing of aging population cause losing ability that need long-care needs, the project entitled "10-year long-term care program" from Executive Yuan in 2007 is carried out to assist economically disadvantaged and disabled elderly to acquire daily nutrition. Therefore, the long-term care resident's nutritional status got more attention than before. Out of control in blood glucose will not only increase bed sores and urinary tract infection in tube feeding residents but also rise medical expenditures. The nutritional status of long-term care institutions, anyang homes and nursing home are generally bad in nutrition management due to high cost of nutritional supplements from foreign imports that cause the burden of families. In this study, we will recruit diabetic subjects that divide into white sweet potato group (experimental group) and commercial formula group (control group) by using randomized, parallel and open clinical study through tube feeding in sixty days.
Eligibility Criteria
Inclusion Criteria
- Long-term stability nasogastric or gastrostomy-fed person.
- The physician diagnosed as diabetic and regular use of hypoglycemic drugs.
Exclusion Criteria
- Psychosis or depression.
- Hba1c> 8.5%.
- High taking nutritional supplements or steroids drugs.
- Have undergone abdominal surgery caused by intestinal sticky.
- Suffering from cancer, ulcers, respiratory infections and other diseases.
- Currently receiving central venous nutrition therapy or intravenous nutrition therapy.
- Liver dysfunction (ALT ≧ 100 U / L), renal insufficiency (creatinine ≧ 3mg / dl), heart failure (NYFc II above), moderate anemia (hemoglobin <9 g / dl).
Data sourced from ClinicalTrials.gov (NCT02711839). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.